Enanta Pharmaceuticals, Inc.

9EP.F·Frankfurt·Healthcare
Compare
9.85−0.35 (−3.43%)today
As of Oct 23, 6:00 PM CEST · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close10.20
Open10.20
Day range9.3010.20
52-week range8.6514.20
Off day high−3.43%
Off 52-week high−30.63%
Volume2.00
Avg. volume (3M)0.00
Market cap286.89M
EPS (TTM)-2.07
Forward P/E-1.79
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.96
Shares outstanding29.13M
Short interest—
Earnings dateNov 16, 2026 (est.)
Analyst target—
Profit margin−96.89%

Against its peers

Compare in full ›
9EP.F ASMB AVIR EDSA IVVD TRDA
Market cap 286.89M 403.95M 324.03M 37.43M 180.81M 171.71M
P/E (TTM) — 19.1 — — — —
Forward P/E -1.8 -7.7 -2.7 — -1.1 -1.5
Price/book 3.2 1.3 1.6 67.6 1.0 0.7
Dividend yield — — — — — —
1-year change +14.61% −30.64% +26.17% +0.73% −72.65% −30.75%
Today −3.43% −2.17% −0.25% +0.36% +0.54% −6.77%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All 9EP.F news ›

From articles in the 4Search news index.

In the news

2mentions in 30 days
2with it in the headline
Negativesentiment

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.